Vote in the European Parliament

Laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006

Date: 10.04.2024·Reference: A9-0141/2024
Rapporteur: Tiemo Wölken
For488
  • 488 For
  • 67 Against
  • 34 Abstention
  • 116 Did not vote

Status

Adopted

Outcome as recorded by the European Parliament.

Vote held on

Procedure timeline

No procedure timeline is available for this vote yet.

Sources

Data: EP Open Data API

What is this about?

P9_PV(2024)04-10(RCV)

  • Reform strengthens access to medicines in the EU.
  • EMA gains expanded powers for authorization and monitoring.
  • Focus on environmental sustainability and „One Health“ approach.
Source: AI Summary with Mistral

Vote by political group

How the political groups voted

Members

Showing 10 of 705

Vote Position
NameCountryGroupVote Position
PortugalS&D
For
BulgariaEPP
For
SpainS&D
For
SwedenS&D
For
SpainS&D
For
DenmarkRenew
For
FranceNI
For
BulgariaEPP
For
AustriaS&D
For
SwedenS&D
For
Show more
Follow us on Instagram@checksomevotes@checksomevotes_en